<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>cardiovascular medicine</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>cardiovascular medicine | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Neurodegeneration is strongly linked to heart failure severity and outcomes: framing the cardiocerebral syndrome
Authors: Wurm, R.; Prausmueller, S.; Ponleitner, M.; Spinka, G.; Weidenhammer, A.; Arfsten, H.; Heitzinger, G.; Panagiotides, N. G.; Bartko, P.; Goliasch, G.; Stoegmann, E.; Hengstenberg, C.; Huelsmann, M.; Pavo, N.
Score: 1.2, Published: 2023-09-15 DOI: 10.1101/2023.09.15.23295547
Background and ObjectivesCognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/cardiovascular-medicine/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="cardiovascular medicine" />
<meta property="og:description" content="Neurodegeneration is strongly linked to heart failure severity and outcomes: framing the cardiocerebral syndrome
Authors: Wurm, R.; Prausmueller, S.; Ponleitner, M.; Spinka, G.; Weidenhammer, A.; Arfsten, H.; Heitzinger, G.; Panagiotides, N. G.; Bartko, P.; Goliasch, G.; Stoegmann, E.; Hengstenberg, C.; Huelsmann, M.; Pavo, N.
Score: 1.2, Published: 2023-09-15 DOI: 10.1101/2023.09.15.23295547
Background and ObjectivesCognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/cardiovascular-medicine/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-09-24T10:37:06+00:00" />
<meta property="article:modified_time" content="2023-09-24T10:37:06+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="cardiovascular medicine"/>
<meta name="twitter:description" content="Neurodegeneration is strongly linked to heart failure severity and outcomes: framing the cardiocerebral syndrome
Authors: Wurm, R.; Prausmueller, S.; Ponleitner, M.; Spinka, G.; Weidenhammer, A.; Arfsten, H.; Heitzinger, G.; Panagiotides, N. G.; Bartko, P.; Goliasch, G.; Stoegmann, E.; Hengstenberg, C.; Huelsmann, M.; Pavo, N.
Score: 1.2, Published: 2023-09-15 DOI: 10.1101/2023.09.15.23295547
Background and ObjectivesCognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "cardiovascular medicine",
      "item": "https://trxiv.yorks0n.com/posts/cardiovascular-medicine/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "cardiovascular medicine",
  "name": "cardiovascular medicine",
  "description": "Neurodegeneration is strongly linked to heart failure severity and outcomes: framing the cardiocerebral syndrome\nAuthors: Wurm, R.; Prausmueller, S.; Ponleitner, M.; Spinka, G.; Weidenhammer, A.; Arfsten, H.; Heitzinger, G.; Panagiotides, N. G.; Bartko, P.; Goliasch, G.; Stoegmann, E.; Hengstenberg, C.; Huelsmann, M.; Pavo, N.\nScore: 1.2, Published: 2023-09-15 DOI: 10.1101/2023.09.15.23295547\nBackground and ObjectivesCognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes.",
  "keywords": [
    
  ],
  "articleBody": " Neurodegeneration is strongly linked to heart failure severity and outcomes: framing the cardiocerebral syndrome\nAuthors: Wurm, R.; Prausmueller, S.; Ponleitner, M.; Spinka, G.; Weidenhammer, A.; Arfsten, H.; Heitzinger, G.; Panagiotides, N. G.; Bartko, P.; Goliasch, G.; Stoegmann, E.; Hengstenberg, C.; Huelsmann, M.; Pavo, N.\nScore: 1.2, Published: 2023-09-15 DOI: 10.1101/2023.09.15.23295547\nBackground and ObjectivesCognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes. Novel blood-based biomarkers have emerged as potential diagnostic tools for neurodegeneration. This study aimed to assess neurodegeneration in HFrEF by measuring neurofilament light chain (NfL), total tau (t-tau), amyloid-beta 42 (A{beta}42), and 40 (A{beta}40) in a large, well-characterised cohort. MethodsThe study included 470 HFrEF patients from a biobank-linked prospective registry at the Medical University of Vienna. High-sensitivity single-molecule assays were used for measurement. Unplanned hospitalisations and all-cause death were recorded as outcome parameters. ResultsAll markers, but not the A{beta}42/A{beta}40 ratio, correlated with heart failure (HF) severity, i.e. NTproBNP and NYHA class, comorbidity burden and were significantly associated with all-cause death and HF-hospitalisations [crude HR for 1-log unit increase (95%CI): 4.44 (3.02-6.53), 5.04 (2.97-8-58), 3.90 (2.27-6.72) and 5.14 (2.84-9.32) for all-cause death and 2.48 (1.60-3.85), 3.44 (1.95-6.04), 3.13 (1.84-5.34) and 3.48 (1.93-6.27) for HHF, p\u003c0.001 for all]. These markers remained significant after adjustment in multivariate models including NT-proBNP. NfL and t-tau showed the highest prognostic ability in the receiver operating characteristic analysis [AUC: 0.72, 0.68, 0.66, 0.67 for NfL, t-tau, A{beta}40 and A{beta}42, respectively]. The performance of NfL was comparable to that of NT-proBNP [C-index: 0.70 vs 0.72, p=0.225]. ConclusionsNeurodegeneration is directly interwoven with the progression of HF. Biomarkers, particularly NfL, may help identify patients profiting from detailed neurological workups. Further research is necessary to test if early diagnosis or optimised HFrEF treatment can preserve cognitive function.\nUsing a polygenic score to account for genomic risk factors in a model to detect individuals with dilated ascending thoracic aortas\nAuthors: DePaolo, J.; Biagetti, G.; Judy, R.; Wang, G.; Kelly, J.; Iyengar, A.; Goel, N.; Desai, N.; Szeto, W. Y.; Bavaria, J. E.; Levin, M.; Damrauer, S. M.\nScore: 1.2, Published: 2023-09-08 DOI: 10.1101/2023.09.06.23295145\nBackgroundAscending thoracic aortic dilation is a complex trait that involves modifiable and non-modifiable risk factors and can lead to thoracic aortic aneurysm and dissection. Clinical risk factors have been shown to predict ascending thoracic aortic diameter. Polygenic scores (PGS) are increasingly used to assess clinical risk for multifactorial diseases. The degree to which a PGS can improve aortic diameter prediction is not known. In this study we tested the extent to which the addition of a PGS to clinical prediction algorithms improves the prediction of aortic diameter. MethodsThe patient cohort comprised 6,790 Penn Medicine Biobank (PMBB) participants with available echocardiography and clinical data linked to genome-wide genotype data. Linear regression models were used to integrate PGS weights derived from a large genome wide association study of thoracic aortic diameter in the UK biobank and were compared to the performance of the standard and a reweighted variation of the recently published AORTA Score. ResultsCohort participants were 56% male, had a median age of 61 years (IQR 52-70) with a mean ascending aortic diameter of 3.4 cm (SD 0.5). Compared to the AORTA Score which explained 28.4% (95% CI 28.1% to 29.2%) of the variance in aortic diameter, AORTA Score + PGS explained 28.8%, (95% CI 28.1% to 29.6%), the reweighted AORTA score explained 30.4% (95% CI 29.6% to 31.2%), and the reweighted AORTA Score + PGS explained 31.0% (95% CI 30.2% to 31.8%). The addition of a PGS to either the AORTA Score or the reweighted AORTA Score improved model sensitivity for the identifying individuals with a thoracic aortic diameter [\u0026ge;] 4 cm. The respective areas under the receiver operator characteristic curve for the AORTA Score + PGS (0.771, 95% CI 0.756 to 0.787) and reweighted AORTA Score + PGS (0.785, 95% CI 0.770 to 0.800) were greater than the standard AORTA Score (0.767, 95% CI 0.751 to 0.783) and reweighted AORTA Score (0.780 95% CI 0.765 to 0.795). ConclusionsWe demonstrated that inclusion of a PGS to the AORTA Score results in a small but clinically meaningful performance enhancement. Further investigation is necessary to determine if combining genetic and clinical risk prediction improves outcomes for thoracic aortic disease.\n",
  "wordCount" : "708",
  "inLanguage": "en",
  "datePublished": "2023-09-24T10:37:06Z",
  "dateModified": "2023-09-24T10:37:06Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/cardiovascular-medicine/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      cardiovascular medicine
    </h1>
    <div class="post-meta"><span>updated on September 24, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.15.23295547">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.15.23295547" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.15.23295547">
        <p class="paperTitle">Neurodegeneration is strongly linked to heart failure severity and outcomes: framing the cardiocerebral syndrome</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.15.23295547" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.15.23295547" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wurm, R.; Prausmueller, S.; Ponleitner, M.; Spinka, G.; Weidenhammer, A.; Arfsten, H.; Heitzinger, G.; Panagiotides, N. G.; Bartko, P.; Goliasch, G.; Stoegmann, E.; Hengstenberg, C.; Huelsmann, M.; Pavo, N.</p>
        <p class="info">Score: 1.2, Published: 2023-09-15 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.15.23295547' target='https://doi.org/10.1101/2023.09.15.23295547'> 10.1101/2023.09.15.23295547</a></p>
        <p class="abstract">Background and ObjectivesCognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes. Novel blood-based biomarkers have emerged as potential diagnostic tools for neurodegeneration. This study aimed to assess neurodegeneration in HFrEF by measuring neurofilament light chain (NfL), total tau (t-tau), amyloid-beta 42 (A{beta}42), and 40 (A{beta}40) in a large, well-characterised cohort.

MethodsThe study included 470 HFrEF patients from a biobank-linked prospective registry at the Medical University of Vienna. High-sensitivity single-molecule assays were used for measurement. Unplanned hospitalisations and all-cause death were recorded as outcome parameters.

ResultsAll markers, but not the A{beta}42/A{beta}40 ratio, correlated with heart failure (HF) severity, i.e. NTproBNP and NYHA class, comorbidity burden and were significantly associated with all-cause death and HF-hospitalisations [crude HR for 1-log unit increase (95%CI): 4.44 (3.02-6.53), 5.04 (2.97-8-58), 3.90 (2.27-6.72) and 5.14 (2.84-9.32) for all-cause death and 2.48 (1.60-3.85), 3.44 (1.95-6.04), 3.13 (1.84-5.34) and 3.48 (1.93-6.27) for HHF, p&lt;0.001 for all]. These markers remained significant after adjustment in multivariate models including NT-proBNP. NfL and t-tau showed the highest prognostic ability in the receiver operating characteristic analysis [AUC: 0.72, 0.68, 0.66, 0.67 for NfL, t-tau, A{beta}40 and A{beta}42, respectively]. The performance of NfL was comparable to that of NT-proBNP [C-index: 0.70 vs 0.72, p=0.225].

ConclusionsNeurodegeneration is directly interwoven with the progression of HF. Biomarkers, particularly NfL, may help identify patients profiting from detailed neurological workups. Further research is necessary to test if early diagnosis or optimised HFrEF treatment can preserve cognitive function.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.06.23295145">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.06.23295145" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.06.23295145">
        <p class="paperTitle">Using a polygenic score to account for genomic risk factors in a model to detect individuals with dilated ascending thoracic aortas</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.06.23295145" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.06.23295145" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: DePaolo, J.; Biagetti, G.; Judy, R.; Wang, G.; Kelly, J.; Iyengar, A.; Goel, N.; Desai, N.; Szeto, W. Y.; Bavaria, J. E.; Levin, M.; Damrauer, S. M.</p>
        <p class="info">Score: 1.2, Published: 2023-09-08 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.06.23295145' target='https://doi.org/10.1101/2023.09.06.23295145'> 10.1101/2023.09.06.23295145</a></p>
        <p class="abstract">BackgroundAscending thoracic aortic dilation is a complex trait that involves modifiable and non-modifiable risk factors and can lead to thoracic aortic aneurysm and dissection. Clinical risk factors have been shown to predict ascending thoracic aortic diameter. Polygenic scores (PGS) are increasingly used to assess clinical risk for multifactorial diseases. The degree to which a PGS can improve aortic diameter prediction is not known. In this study we tested the extent to which the addition of a PGS to clinical prediction algorithms improves the prediction of aortic diameter.

MethodsThe patient cohort comprised 6,790 Penn Medicine Biobank (PMBB) participants with available echocardiography and clinical data linked to genome-wide genotype data. Linear regression models were used to integrate PGS weights derived from a large genome wide association study of thoracic aortic diameter in the UK biobank and were compared to the performance of the standard and a reweighted variation of the recently published AORTA Score.

ResultsCohort participants were 56% male, had a median age of 61 years (IQR 52-70) with a mean ascending aortic diameter of 3.4 cm (SD 0.5). Compared to the AORTA Score which explained 28.4% (95% CI 28.1% to 29.2%) of the variance in aortic diameter, AORTA Score &#43; PGS explained 28.8%, (95% CI 28.1% to 29.6%), the reweighted AORTA score explained 30.4% (95% CI 29.6% to 31.2%), and the reweighted AORTA Score &#43; PGS explained 31.0% (95% CI 30.2% to 31.8%). The addition of a PGS to either the AORTA Score or the reweighted AORTA Score improved model sensitivity for the identifying individuals with a thoracic aortic diameter [&amp;ge;] 4 cm. The respective areas under the receiver operator characteristic curve for the AORTA Score &#43; PGS (0.771, 95% CI 0.756 to 0.787) and reweighted AORTA Score &#43; PGS (0.785, 95% CI 0.770 to 0.800) were greater than the standard AORTA Score (0.767, 95% CI 0.751 to 0.783) and reweighted AORTA Score (0.780 95% CI 0.765 to 0.795).

ConclusionsWe demonstrated that inclusion of a PGS to the AORTA Score results in a small but clinically meaningful performance enhancement. Further investigation is necessary to determine if combining genetic and clinical risk prediction improves outcomes for thoracic aortic disease.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
